The Treatment of Moderately Advanced Carcinoma with Chemo-Immunotherapy
- VernacularTitle:中晚期肝细胞癌的化学免疫疗法
- Author:
Chengwei CHEN
;
Liuda NI
;
Sujuan RU
- Publication Type:Journal Article
- Keywords:
moderately advanced hepatocellular carcinoma;
chemo-immunotherapy (GIT);
transarterial chemo-e mbolization (TACE)
- From:
Chinese Journal of Cancer Biotherapy
1996;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
A comparison of effectiveness of chemo-immunotherapy (CIT) using LAK/CD3AK 1-2 weeks after TACE in 74 patients with no surgical indication and TACE alone in 41 patients with moderately advanced HCC was carried out. The rates of remission between CIT group and TACE alone group were 72.4% and 40.4%(P
